SPK-601
CAS No. 1096687-52-3
SPK-601( LMV-601 | SPK-0601 )
Catalog No. M10375 CAS No. 1096687-52-3
A potent phosphatidylcholine-specific phospholipase C (PC-PLC) inhibitor; shows antiviral activity against herpes simplex virus (HSV).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 215 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSPK-601
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent phosphatidylcholine-specific phospholipase C (PC-PLC) inhibitor; shows antiviral activity against herpes simplex virus (HSV).
-
DescriptionA potent phosphatidylcholine-specific phospholipase C (PC-PLC) inhibitor; shows antiviral activity against herpes simplex virus (HSV); a novel antimicrobial agent.HSV Infection Phase 1 Clinical.
-
In VitroSPK-601 (72 hours; HPV-31 cells) displays a dose dependent inhibitory effect on cell growth (IC50 of 16 μg/mL), and inhibits HPV-31 specific RNA expression and DNA replication. Cell Viability Assay Cell Line:9E human papilloma virus (HPV)-31 infected cervical epithelial cells Concentration:Incubation Time:72 hours Result:A dose dependent inhibitory effect on cell growth.
-
In Vivo——
-
SynonymsLMV-601 | SPK-0601
-
PathwayMetabolic Enzyme/Protease
-
TargetPhospholipase
-
RecptorPhospholipase
-
Research AreaInfection
-
IndicationHSV Infection
Chemical Information
-
CAS Number1096687-52-3
-
Formula Weight266.4645
-
Molecular FormulaC11H15KOS2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILES[S-]C(O[C@@H]1[C@@](C2)([H])[C@]3([H])CCCC3[C@@]2([H])C1)=S.[K+]
-
Chemical NameCarbonodithioic acid, O-[(3aR,4R,5S,7R,7aR)-octahydro-4,7-methano-1H-inden-5-yl] ester, potassium salt (1:1), rel-(-)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Walker K. IDrugs. 2010 Nov;13(11):743-5.
molnova catalog
related products
-
CCT129957
CCT129957 is a novel and potent phospholipase C-γ (PLC-γ) inhibitor with an IC50 of about 3 μM and a GC50 of 15 μM.CCT129957 exhibits anticancer activity and inhibits Ca2+ release in squamous cells.
-
Lp-PLA2-IN-3
Lp-PLA2-IN-3 is a potent, orally bioactive lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor, effectively inhibiting recombinant human [Lp-PLA2] with an IC50 value of 14 nM.
-
Atg4B-IN-2
Atg4B-IN-2. A potent, selective Atg4B inhibitor with anticancer activity, inhibits both Atg4B and PLA2, enabling autophagy that counteracts the anticancer activity of anti-desiccation-resistant prostate cancer drugs.
Cart
sales@molnova.com